10 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
, foreign governments and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions … not suitable for intensive therapy may be offered the option for low-intensity therapy such as low-dose cytarabine, azacitidine or decitabine
10-K
sq7s27b4
3 Apr 17
Annual report
12:00am
- Prev
- 1
- Next